NCT05098197View on ClinicalTrials.gov

Study on TIL for the Treatment of Advanced Hepatobiliary-Pancreatic Cancers

EARLY_PHASE1RecruitingINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

September 26, 2021

Primary Completion Date

September 25, 2026

Study Completion Date

September 25, 2026

Conditions
Advanced Liver CancersTumor Infiltrating LymphocyteTreatment Side EffectsEffects of ImmunotherapyAdvanced Pancreatic Cancers
Interventions
BIOLOGICAL

Tumor Infiltrating Lymphocyte

Adoptive transfer of 1x10\^9-5x10\^10 autologous TILs to patients i.v. in 30-120 minutes.

Trial Locations (1)

200000

RECRUITING

Shanghai Tenth People's Hospital, Shanghai

All Listed Sponsors
collaborator

Shanghai 10th People's Hospital

OTHER

lead

Shanghai Juncell Therapeutics

INDUSTRY